CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Development of end-use industries
4.1.2. Increasing incidence of target indications
4.1.3. Availability of funding for stem cell research
4.1.4. Technological advancements in stem cell-based research instruments and introduction
of novel stem cell products
4.2. Market Restraints & Challenges
4.2.1. The high cost of stem cell analysis instruments and reagents
4.2.2. Survival of small players and new entrants
4.3. Market Opportunities
4.3.1. The emergence of microfluidics in stem cell research
4.3.2. High growth potential of single stem cell analysis sequencing
CHAPTER 5. GLOBAL STEM CELL ASSAYS MARKET – BY TYPE
5.1. Introduction
5.2. Isolation & purification assays
5.3. Viability/cytotoxicity assays
5.4. Differentiation assays
5.5. Cell identification assays
5.6. Proliferation assays
5.7. Function assays
5.8. Apoptosis assays
CHAPTER 6. GLOBAL STEM CELL ASSAYS MARKET – BY CELL TYPE
6.1. Introduction
6.2. Human embryonic stem cells
6.2.1. Adult stem cells market, by type
6.2.1.1. Hematopoietic stem cells
6.2.1.2. Mesenchymal stem cells
6.2.1.3. Cells umbilical cord stem cells
6.2.1.4. Induced pluripotent stem
6.2.1.5. Neural stem cells
6.3. Adult stem cells
CHAPTER 7. GLOBAL STEM CELL ASSAYS MARKET – BY PRODUCT &
SERVICE
7.1. Introduction
7.2. Services
7.2.1 Instruments Market, By Type
7.2.1.1. Microelectrode arrays
7.2.1.2. Cell imaging systems
7.2.1.3. Automated cell counters
7.2.1.4. Flow cytometers
7.3. Kits
7.4. Instruments
CHAPTER 8. GLOBAL STEM CELL ASSAYS MARKET - BY APPLICATION
8.1. Introduction
8.2. Regenerative medicine & therapy development
8.2.1. Orthopedic & musculoskeletal spine applications
8.2.2. Oncology
8.2.3. Cardiovascular applications
8.2.4. Central nervous system applications
8.2.5. Dermatology
8.2.6. Diabetes
8.2.7. Other applications
8.3. Drug discovery & development
8.4. Clinical research
CHAPTER 9. GLOBAL STEM CELL ASSAYS MARKET - BY END USER
9.1. Introduction
9.2. Biopharmaceutical & biotechnology companies
9.3. Research institutes
CHAPTER 10. GLOBAL STEM CELL ASSAYS MARKET - BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL STEM CELL ASSAYS MARKET - COMPANY PROFILES
11.1. GE Healthcare
11.2. Promega Corporation.
11.3. Thermo Fisher Scientific.
11.4. The Merck Group
11.5. Cell Biolabs, Inc.
11.6. Hemogenix.
11.7. STEMCELL Technologies Inc.
11.8. Bio-Rad Laboratories, Inc.
11.10. Bio-Techne Corporation.,
11.11. Cellular Dynamics International Inc.
11.12. Agilent Technologies.
11.13. Merck & Company, Inc.
11.14. International Medical Group.
11.14. UnitedHealth Group Inc.
11.15. Allianz SE.
CHAPTER 12. GLOBAL STEM CELL ASSAYS MARKET - COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
